Jitolina ME 2.5/500 Tablet (10 Tab)

Jitolina ME 2.5/500 Tablet Overview:

Jitolina ME 2.5/500 Tablet is an oral anti-diabetic medication used to manage high blood sugar levels associated with Type 2 Diabetes Mellitus.

Type 2 diabetes can lead to serious complications, including cardiovascular disease such as heart attack and stroke, as well as kidney damage, nerve damage, vision problems, slow wound healing, etc.

This dual-action formulation containing linagliptin and metformin is prescribed along with diet and exercise when lifestyle modifications and previous treatment with a single oral antidiabetic medication do not provide adequate blood sugar control.

Jitolina ME 2.5/500 Tablet works systematically to stimulate insulin release, improve insulin sensitivity, and reduce excess glucose production in the liver. Therefore, it provides better glycemic control and reduces the risk of serious diabetes-related complications.

It is important to note that Jitolina ME 2.5/500 Tablet is not for the treatment of Type 1 diabetes or diabetic ketoacidosis.

Composition:

Each film coated tablet contains- Linagliptin: 2.5 mg and Metformin: 500 mg.

Colour: Ferric Oxide Yellow and Titanium Dioxide

Uses & Benefits of Jitolina ME 2.5/500 Tablet:

Jitolina ME 2.5/500 Tablet is primarily used for the treatment of Type 2 Diabetes Mellitus, also known as non-insulin-dependent diabetes mellitus (NIDDM).

How Does Jitolina ME 2.5/500 Tablet Work:

Jitolina ME 2.5/500 Tablet contains Linagliptin, a DPP-4 inhibitor, and Metformin, a biguanide, which work together through two distinct mechanisms to manage blood sugar levels.

Linagliptin works as a DPP-4 inhibitor by blocking the enzyme responsible for breaking down "incretin" hormones. By preventing the breakdown of incretin hormones, it triggers the pancreas to release more insulin when blood sugar levels rise and signals the liver to decrease its sugar production.

Whereas Metformin focuses on improving the body's natural response to insulin. It enhances insulin sensitivity at the cellular level while simultaneously reducing the amount of glucose produced by the liver and absorbed from the digestive tract. Together, these two mechanisms provide a comprehensive approach to maintaining stable, healthy blood glucose levels throughout the day.

Dosage of Jitolina ME 2.5/500 Tablet:

• Usage Direction

Take Jitolina ME 2.5/500 Tablet strictly according to your doctor’s instructions, following the prescribed dose and timing. Jitolina ME 2.5/500 Tablet should be swallowed as whole with water and not to be chewed, or crushed, preferably at the same time each day. Do not stop or alter the dose of Jitolina ME 2.5/500 Tablet without consulting your doctor, as this may prevent you from achieving the desired outcome. If you are unsure about the administration procedures of Jitolina ME, consult with your doctor or pharmacist.

• Missed Dose

If you miss a dose of Jitolina ME 2.5/500 Tablet, take it as soon as you remember on the same day. But, if it is almost time for your next scheduled dose, skip the one you missed and continue following your regular dosing schedule. Do not attempt to take two doses if you have forgotten one. If you often forget to take your medication, consult with your doctor to re-evaluate your dosing schedule. Frequently missing doses could lead to undesired outcomes.

You can set reminders on your smartphone, keep drug organizer boxes, or use other audio-visual technologies to prevent missing a dose.

• Overdose

If you accidentally take Jitolina ME 2.5/500 Tablet more than your prescribed dose, seek immediate medical advice, as this may lead to serious side effects. Symptoms of overdose may include severe hypoglycemia (low blood sugar) or lactic acidosis (nausea, stomach pain, muscle cramps, or breathing difficulty).

Management of overdose could be through supportive care, such as administration of glucose or removal of unabsorbed drug from the GI tract in case of hypoglycaemia. Whereas, in cases of lactic acidosis, hemodialysis may be required to clear the medication from the bloodstream.

Contraindications of Jitolina ME 2.5/500 Tablet:

Do not take Jitolina ME 2.5/500 Tablet if you are allergic to Linagliptin, Metformin, or any other ingredients of this medicine. This medicine is contraindicated in patients with type 1 diabeletes mellitus, severe metabolic complications, such as diabetic ketoacidosis, diabetic pre-coma, or lactic acidosis.

Additionally, this medication is not suitable for those with severe renal or hepatic impairment, as these conditions can interfere with the safe processing of the drug.

Use should also be avoided in patients with significant cardiovascular or respiratory issues, including acute heart failure, recent heart attack (myocardial infarction), or severe circulatory failure, as these conditions increase the risk of serious adverse reactions.

Also, Jitolina ME 2.5/500 Tablet is not for children and adolescents below 18 years of age.

Precautions & Warnings of Jitolina ME 2.5/500 Tablet:

Before taking Jitolina ME 2.5/500 Tablet, inform your doctor if you are aged 65 or older or have a history of pancreatitis, heart failure, or a kidney problem. This medication requires careful supervision in patients with uncontrolled diabetes due to the risk of lactic acidosis, a rare but serious metabolic complication. Immediate medical attention is necessary if symptoms such as persistent vomiting, abdominal pain, muscle cramps, breathing difficulty, unusual tiredness, reduced body temperature, or heartbeat occur.

Furthermore, while this tablet is effective for glycemic control, using it alongside other anti-diabetic drugs may increase the risk of hypoglycemia (low blood sugar). It is equally important to stay hydrated and consult a doctor during severe infections or diarrhea, as dehydration can impair kidney function.

Additionally, regular monitoring of kidney function is essential while on this medication to ensure long-term renal health and drug safety, as the kidneys are responsible for clearing this medication from the body.

Side Effects of Jitolina ME 2.5/500 Tablet:

While Jitolina ME 2.5/500 Tablet is generally well-tolerated, some patients may side effect of this medication is hypoglycemia (low blood sugar), which can be followed by trembling, sweating, anxiety, blurred vision, or confusion.

Common gastrointestinal symptoms may also occur, including nausea, vomiting, diarrhea, and stomach pain, alongside occasional flu-like symptoms or nasopharyngitis.

Although rare, certain serious side effects require immediate medical intervention. These include signs of lactic acidosis or severe allergic reactions such as skin rashes, intense itching (pruritus), hives (urticaria), or swelling (angioedema). More specialized dermatological conditions, such as bullous pemphigoid, or signs of liver inflammation (hepatitis), should also be reported to a healthcare provider immediately.

Safety Related Concerns of Jitolina ME 2.5/500 Tablet:

• Pregnancy

Jitolina ME 2.5/500 Tablet is generally not recommended during pregnancy, as there is limited data on the safety of Linagliptin during pregnancy. If you are pregnant or planning to become pregnant while taking Jitolina ME, consult your healthcare provider immediately. Your healthcare provider may switch to insulin or other safer alternatives to maintain normal blood sugar levels.

Careful and regular blood glucose monitoring during pregnancy is essential to reduce the risk of complications and support healthy fetal development. Always follow your doctor’s advice and do not start or stop any diabetes medication without medical guidance.

• Breastfeeding

It is advisable to avoid using the Jitolina ME 2.5/500 Tablet while breastfeeding, as metformin can be transferred through breast milk and may affect the breastfed child. Therefore, consulting with your doctor before taking Jitolina ME 2.5/500 Tablet is necessary.

• Alcohol

Avoid alcohol consumption while taking Jitolina ME 2.5/500 Tablet, as it may increase the risk of lactic acidosis and can cause unpredictable fluctuation in blood sugar levels. Before taking the medicine, inform your doctor if you consume alcohol.

• Food Interactions

Jitolina ME 2.5/500 Tablet can be taken with or without food. Your doctor may prescribe it after or with a meal, as it might help reduce gastrointestinal side effects. However, maintaining a healthy diet is essential for regulating blood glucose levels, which can be achieved by avoiding sugary items and high-fat foods, and by limiting carbohydrates, as these are primarily responsible for glucose spikes and gastrointestinal side effects. Focusing on nutrient-dense, fiber-rich foods helps regulate the rate of sugar absorption, thereby enhancing the overall effectiveness of the treatment.

• Drug Interactions

Jitolina ME 2.5/500 Tablet can interact with various medications, either by altering the effectiveness or increasing the risk of adverse reactions. It is crucial to inform your healthcare provider if you are taking diuretics (water pills), as they can increase the risk of dehydration.

Furthermore, combining this tablet with other anti-diabetic agents like insulin or sulfonylureas significantly increases the risk of hypoglycemia (low blood sugar), often requiring careful dose adjustments.

Certain medications may reduce the clinical efficacy of this treatment or increase toxicity, including specific steroids, bronchodilators, and anti-seizure medications like phenobarbital or phenytoin. Other drugs, such as verapamil, rifampicin, cimetidine, and certain NSAIDs (like ibuprofen), can also interfere with how the body processes Metformin and Linagliptin.

Always inform your healthcare provider and pharmacist about all medications you are taking, including prescription drugs, over-the-counter medications, vitamins, minerals, and herbal supplements, to avoid potential interactions.

• Using Machinery & Driving

Using Jitolina ME 2.5/500 Tablet may affect your ability to drive or operate machinery, especially when taken with other antidiabetic medicines such as insulin or sulphonylureas. These combinations can cause low blood sugar (hypoglycemia), which may lead to symptoms like blurred vision, dizziness, shaking, sweating, or confusion.

It is important to recognize early signs of low blood sugar and avoid driving or risky activities if you feel unwell or dizzy. Always carry a quick source of glucose, such as fruit juice or sugar tablets, and monitor your blood sugar regularly during treatment.

Storage of Jitolina ME 2.5/500 Tablet:

Store protected from light & moisture at a temperature not exceeding 25°C. Keep the medicine out of reach of children.

Avoid using it after the expiry date, printed on the packaging. Dispose of expired or unused medication properly; do not throw it away casually.

Helpful Tips:

• Diabetes can be managed through a balanced diet (low glycemic index foods) and regular physical activity (at least 30 minutes daily) under medical supervision.
• Monitor your blood glucose levels regularly as advised by your doctor to ensure the dosage is optimal.
• Check your feet daily for any cuts or sores, as it is one of the chronic complication of diabetes. And if any wound appears proper care should be done, as diabetes slows down healing.
• Make sure to have quick sugar supplies on hand for low blood sugar episodes.
• Do not suddenly stop your medication unless your doctor specifically tells you to.
• Do not share your medicine with someone else having the same symptoms as you, as the drug requires a prescription.

Frequently Asked Questions (FAQs):

Q. What is Jitolina ME 2.5/500 Tablet used for?

A. Jitolina ME 2.5/500 Tablet is an oral medication for diabetes, specifically for adults with Type 2 Diabetes Mellitus. It is prescribed as an adjunct to diet and exercise to help patients achieve better glycemic control. By combining two active ingredients, the medication effectively reduces liver glucose production, enhances the body's sensitivity to insulin, and stimulates the natural release of insulin. This comprehensive approach helps stabilize blood sugar levels throughout the day and lowers the risk of long-term diabetes-related complications.

Q. Can I stop taking L Jitolina ME inanext M ER if my sugar levels are normal?

A. No, you should not stop taking Jitolina ME without consulting your doctor first. Diabetes is a chronic condition, and the medication helps keep your sugar levels stable. Stopping the medication abruptly can lead to a dangerous spike in sugar levels.

Q. How does alcohol affect my treatment with Jitolina ME 2.5/500 Tablet?

A. It is highly recommended to avoid or strictly limit alcohol consumption while on this medication. Alcohol significantly increases the risk of lactic acidosis, a rare but life-threatening metabolic complication associated with Metformin. Additionally, alcohol can cause unpredictable fluctuations in blood sugar levels, making your diabetes harder to manage.

Q. Is Jitolina ME 2.5/500 Tablet suitable for Type 1 Diabetes?

A. No, this medication is specifically formulated for patients with Type 2 Diabetes, where the body still produces some insulin but cannot use it effectively. It is not effective for treating Type 1 Diabetes, where the body produces little to no insulin, nor is it intended for the treatment of diabetic ketoacidosis.

Q. Is Jitolina ME 2.5/500 Tablet safe for patients with kidney problems?

A. The safety of this medication depends entirely on the severity of the renal impairment. Because Metformin is cleared through the kidneys, it is generally contraindicated in patients with severe kidney disease or failure. For those with mild to moderate kidney issues, a physician may prescribe a reduced dose and will require regular monitoring of kidney function (eGFR) to prevent the drug from reaching toxic levels in the bloodstream.

Q. What should I do if I experience blurred vision?

A. Blurred vision can be a clinical symptom of hypoglycemia (dangerously low blood sugar), which may occur if your blood glucose levels drop too quickly. If this happens, you should immediately consume a fast-acting source of sugar, such as 3–4 glucose tablets, half a cup of fruit juice, or a tablespoon of honey or sugar. Once your symptoms begin to stabilize, it is important to contact your healthcare provider to discuss the episode, as they may need to adjust your dosage or review your meal timings. If the blurred vision persists or is accompanied by severe dizziness or confusion, seek medical attention immediately.

References:

1. JITOLINA ?? 2.5/500. Linagliptin and Metformin Hydrochloride Tablets (2.5mg + 500mg). Accessed on: 10th August 2026. Click Here

2. JENTADUETO. linagliptin and metformin hydrochloride tablets. PRODUCT MONOGRAPH. Last Revised: June 12, 2020. Accessed on: 10th August 2026. Click Here

3. Trajentamet. Linagliptin / Metformin Hydrochloride. Consumer Medicine Information. Last Revised: May 2026. Accessed on: 10th August 2026. Click Here

4. LINAXA M 2.5/ 500. Linagliptin and Metformin Hydrochloride tablets 2.5 mg +500 mg, 2.5 mg+ 850 mg and 2.5 mg+1000 mg. Last Revised: April 2023. Accessed on: 10th August 2026. Click Here